Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
NEJM April 2026: Volume 394, Issue 16 – Medical Research & Articles - News Directory 3

NEJM April 2026: Volume 394, Issue 16 – Medical Research & Articles

April 29, 2026 Jennifer Chen Health
News Context
At a glance
  • The New England Journal of Medicine’s April 23, 2026, issue (Volume 394, Issue 16) features several research articles, including a study examining the risk of Guillain-Barré Syndrome following...
  • A study published in the journal investigated the potential link between laboratory-confirmed dengue infection and the development of Guillain-Barré Syndrome (GBS).
  • Research detailed in the issue focuses on the effectiveness of oral nirmatrelvir–ritonavir, a treatment for Covid-19, in higher-risk outpatients.
Original source: nejm.org

The New England Journal of Medicine’s April 23, 2026, issue (Volume 394, Issue 16) features several research articles, including a study examining the risk of Guillain-Barré Syndrome following laboratory-confirmed dengue infection, and research on oral nirmatrelvir–ritonavir for Covid-19 in higher-risk outpatients.

Guillain-Barré Syndrome and Dengue Infection

A study published in the journal investigated the potential link between laboratory-confirmed dengue infection and the development of Guillain-Barré Syndrome (GBS). The research provides data on the incidence of GBS following dengue infection, contributing to a better understanding of the neurological complications associated with this viral illness.

Oral Nirmatrelvir–Ritonavir for Covid-19

Research detailed in the issue focuses on the effectiveness of oral nirmatrelvir–ritonavir, a treatment for Covid-19, in higher-risk outpatients. The study examines the outcomes of patients treated with this antiviral medication, providing insights into its clinical benefits and potential impact on disease progression.

Oral Nirmatrelvir–Ritonavir for Covid-19
Medical Research Volume Oral Nirmatrelvir

The New England Journal of Medicine’s table of contents for the April 23, 2026, issue indicates a range of medical research and clinical studies. The journal covers pages 1561-1664 for this issue.

Other Articles in the Issue

Beyond the studies on dengue and Covid-19, the April 23, 2026, issue of the New England Journal of Medicine includes a variety of other research articles and clinical reports. The journal continues to serve as a leading platform for disseminating cutting-edge medical knowledge to healthcare professionals worldwide.

The journal’s website provides access to previous issues dating back to 1949, allowing researchers and clinicians to explore a comprehensive archive of medical literature. Issues from 2026 are available, with Volume 394 covering the period from January 1, 2026, through April 30, 2026.

The New England Journal of Medicine publishes new issues weekly, providing a continuous stream of updated medical information. The current issue, Volume 394, Issue 16, released on April 23, 2026, is the latest addition to this ongoing resource for the medical community.

NEJM This Week — April 23, 2026

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Worth a look

  • New Guidelines Issued for Alzheimer’s Disease Diagnosis and Detection
  • WHO Lists First Molecular Test for Bundibugyo Virus on Emergency Use Listing

Related

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com